{"id":"W2076333986","doi":"10.1038/nrd3674","title":"Epigenetic protein families: a new frontier for drug discovery","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1308,"is_retracted":false,"has_abstract":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"Ontario Genomics Institute; Wellcome Trust; Canadian Institutes of Health Research; Genome Canada; Ontario Genomics; Pfizer; Eli Lilly and Company","keywords":"Epigenetics; Druggability; Bromodomain; Drug discovery; Biology; Histone; Computational biology; DNA methylation; Epigenomics; Genetics; Histone methyltransferase; Methyltransferase; Methylation; Gene; Biochemistry; Gene expression","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02728672238237669,"score_gpt":0.3438968930108087,"score_spread":0.3166101706284321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}